Brief: Ginkgo Bioworks Holdings And Xprescheck receive award to expand CDC's Traveler-Based Sars-Cov-2 Genomic Surveillance Program in U.S. Airports

XWELL

15/08/2022 13:54

Aug 15 (Reuters) - Ginkgo Bioworks Holdings Inc  DNA.N :
    * GINKGO BIOWORKS AND XPRESCHECK RECEIVE AWARD TO EXPAND
CDC'S
TRAVELER-BASED SARS-COV-2 GENOMIC SURVEILLANCE PROGRAM IN U.S.
AIRPORTS
    * GINKGO BIOWORKS - PARTNERSHIP EXPECTED TO SUPPORT PUBLIC
HEALTH
AND BIOSECURITY SERVICES TOTALING APPROXIMATELY $16 MILLION
    * GINKGO BIOWORKS - PARTNERSHIP HAS AN OVERALL POTENTIAL TO
EXCEED
$61 MILLION BASED ON CDC PROGRAM OPTIONS AND PUBLIC HEALTH
PRIORITIES
    * GINKGO BIOWORKS - PARTNERS PLAN TO EXPAND PROGRAM
FOOTPRINT,
INCORPORATE OFFERINGS, SUCH AS MONITORING OF WASTEWATER FROM
AIRCRAFT LAVATORIES
    * GINKGO BIOWORKS - PROGRAM SLATED TO EXPAND FOOTPRINT WITH
ADDITIONAL TESTING SITES IN EXISTING AIRPORT LOCATIONS
    * GINKGO BIOWORKS - PROGRAM SLATED TO EXPAND FOOTPRINT WITH
NEW
LOCATION AT WASHINGTON DULLES INTERNATIONAL AIRPORT THIS FALL

Source text for Eikon:  ID:nPnc6D0tYa 
Further company coverage:  DNA.N